BHB-1893 Investigational oral cardiac myosin inhibitor in clinical development for obstructive and non-obstructive hypertrophic cardiomyopathy; not approved for commercial use.
Visit productCosigns Received
Be the first Cosign
Put your name behind BHB-1893.
Add it to your Products I use list and share why you use it.